The Republican presidential debates have fueled another round of vaccine anxiety in the U.S. But in the world’s poorest countries, parents have a different set of concerns: They worry about getting their kids immunized quickly enough.
Before you travel internationally, ensure that you are up to date on all your routine vaccines, as well as travel vaccines.
More and more Americans are travelling internationally each year. Today more than a third of Americans have a passport. It is important to remember that some types of international travel, especially to developing countries and rural areas, have higher health risks.
These risks depend on a number of things including:
- Where you are traveling
- Your activities while traveling
- Your current health status
- Your vaccination history
Measles and International Travel
Each year, unvaccinated people get measles while in other countries and bring it to the United States. This has sometimes led to outbreaks. The majority of measles cases brought into the U.S. come from U.S. residents. When we can identify vaccine status, almost all are unvaccinated.
Vaccination is the best protection against measles. Before leaving for trips abroad, make sure you and your family are protected against measles. Plan ahead and check with your doctor to see if you and your family need MMR (measles-mumps-rubella) vaccine.
It took 15 years and hundreds of millions of vaccines. But North America and South America have officially eradicated rubella, health authorities said Wednesday. Rubella, also known as German measles, is only the third virus eradicated from people in the Western Hemisphere.
The World Health Organization has admitted serious failings in its handling of the Ebola crisis and pledged reforms to enable it to do better next time, its leadership said in a statement seen by Reuters on Sunday.
From the National Institutes of Health
Poor quality medicines are a real and urgent threat that could undermine decades of successful efforts to combat HIV/AIDS, malaria and tuberculosis, according to the editors of a collection of journal articles published today.
Scientists report up to 41 percent of specimens failed to meet quality standards in global studies of about 17,000 drug samples.
Among the collection is an article describing the discovery of falsified and substandard malaria drugs that caused an estimated 122,350 deaths in African children in 2013. Other studies identified poor quality antibiotics, which may harm health and increase antimicrobial resistance.
However, new methodologies are being developed to detect problem drugs at the point of purchase and show some promise, scientists say. Continue reading
From the National Institutes of Health
The Ebola virus circulating in humans in West Africa is undergoing relatively few mutations, none of which suggest that it is becoming more severe or transmissible, according to a National Institutes of Health study in the journal Science.
The study compares virus sequencing data from samples taken from patients in Guinea (March 2014), Sierra Leone (June 2014) and Mali (November 2014).
Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at Rocky Mountain Laboratories.
“The Ebola virus in the ongoing West African outbreak appears to be stable—that is, it does not appear to be mutating more rapidly than viruses in previous Ebola outbreaks, and that is reassuring,” said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH. “We look forward to additional information to validate this finding, because understanding and tracking Ebola virus evolution are critical to ensuring that our scientific and public health response keeps pace.” Continue reading
A crackdown on corruption in the water sector and increasing investment in infrastructure are essential to avoid conflicts over water, “life’s most vital resource”, a United Nations University report said on Tuesday.
Population growth, economic insecurity, corruption and climate change threaten the stability and the very existence of some nations, the report said.
Don’t Panic – is a one-hour long documentary produced by Wingspan Productions and broadcasted on BBC on the 7th of November 2013.
This month, PATH produced a new tool for diagnosing river blindness, a disease that affects nearly 18 million globally (stats that are often unheard of). It’s the first of its kind, says Nicole Fallat, Communications Officer at PATH.
As the death toll from the West African Ebola outbreak nears 1,400, two American missionaries who received experimental drugs and top-notch healthcare have been released from the hospital.
We spend the hour with Partners in Health co-founder Dr. Paul Farmer discussing what can be done to stop the epidemic and the need to build local healthcare capacity, not just an emergency response.
“The Ebola outbreak, which is the largest in history that we know about, is merely a reflection of the public health crisis in Africa, and it’s about the lack of staff, stuff and systems that could protect populations, particularly those living in poverty, from outbreaks like this or other public health threats,” says Farmer, who has devoted his life to improving the health of the world’s poorest and most vulnerable people.
He is a professor at Harvard Medical School and currently serves as the special adviser to the United Nations on community-based medicine. He has written several books including, “Infections and Inequalities: The Modern Plagues.”
From the US National Institutes of Health
Trial will evaluate vaccine’s safety
Initial human testing of an investigational vaccine to prevent Ebola virus disease will begin next week by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The early-stage trial will begin initial human testing of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) and will evaluate the experimental vaccine’s safety and ability to generate an immune system response in healthy adults.
The pace of human safety testing for experimental Ebola vaccines has been expedited in response to the ongoing Ebola virus outbreak in West Africa.
The study is the first of several Phase 1 clinical trials that will examine the investigational NIAID/GSK Ebola vaccine and an experimental Ebola vaccine developed by the Public Health Agency of Canada and licensed to NewLink Genetics Corp.
The others are to launch in the fall. These trials are conducted in healthy adults who are not infected with Ebola virus to determine if the vaccine is safe and induces an adequate immune response. Continue reading
Climate change is happening, and with that will come more deaths from heat-related illness and disease, according to a report released Tuesday.
The report, spearheaded and funded by investor and philanthropist Thomas Steyer, former Treasury Secretary Hank Paulson, and former New York Mayor Michael Bloomberg, examines many of the effects of climate change for business and individuals.
“One of the most striking findings in our analysis is that increasing heat and humidity in some parts of the country could lead to outside conditions that are literally unbearable to humans, who must maintain a skin temperature below 95°F in order to effectively cool down and avoid fatal heat stroke,” the report’s authors wrote.
The average will be miserable. When your sweat can’t evaporate, you have no way to moderate core body temperature, and some people will die.
Dr. Al Sommer, the dean emeritus of the Bloomberg School of Public Health at Johns Hopkins University in Baltimore, was on the committee that oversaw the development of the report.
He says that often overlooked in the current debate about greenhouse gases and climate change is the effect of global warming on individuals and hospitals. Continue reading